Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

European Stocks Higher; Stimulus Hopes Boost Growth Optimism

Published 02/02/2021, 03:43 AM
Updated 02/02/2021, 03:44 AM
©  Reuters

By Peter Nurse 

Investing.com - European stock markets traded higher Tuesday, helped by signs of progress towards further U.S. stimulus, while concerns over volatile retail-led trading receded. 

At 3:40 AM ET (0840 GMT), the DAX in Germany traded 1.1% higher, the CAC 40 in France rose 1.4% and the U.K.'s FTSE index climbed 0.5%. 

U.S. President Joe Biden sat down late Monday with a group of ten Republican senators to discuss their proposal of a scaled-back Covid-19 stimulus package, in a welcome sign of bipartisan co-operation in Washington.

That said, Biden insisted on keeping the $1.9 trillion price tag that he proposed in January, and senior Democrats later filed a joint budget measure of the same size in a step toward aimed at bypassing Republicans.

Indications that this package may be delivered reasonably quickly buoyed global markets, as well as hopes that economic recovery may not be too far away: vaccination rollouts continue, despite the slow start in continental Europe, and new infections and fatalities are starting to decline slowly in response to lockdowns.

Adding to the optimism were signs that the recent market turmoil caused by retail traders taking on hedge funds over heavily-shorted stocks may be settling down. 

GameStop (NYSE:GME), the stock at the heart of last week’s protest, saw its shares slide 30% on Monday, and they have continued to fall in premarket trading Tuesday. Similarly, silver, which saw heavy buying on Monday, has dropped over 2% so far Tuesday.

In corporate news, Atos (PA:ATOS) stock gained 3.8% after the French IT consulting group ended talks of a potential takeover of U.S. rival DXC Technology. British pub group Marston’s  (LON:MARS) also continued to rise in the wake of rejecting a bid from private equity, gaining 0.3% to an 11-month high.

Fresenius Medical Care (NYSE:FMS) stock slumped 13% after the health care firm warned its adjusted net profit would likely drop this year, due to more of its long-term patients dying of Covid-19, while BP (NYSE:BP) stock fell 3.3% after the oil major reported a full year loss of $5.7 billion, its first in a decade. 

On the data front, the eurozone will publish preliminary fourth-quarter growth numbers later Tuesday, which are expected to confirm that the region's economy shrunk in the year.

Oil prices pushed higher Tuesday, helped by newswire reports that the major oil producers have shown restraint in terms of production levels in January even as prices rose.

U.S. crude oil supply data from the American Petroleum Institute, due later Tuesday, will be keenly awaited, especially after last week’s hefty draw, while OPEC+'s Joint Technical Committee is also due to discuss the state of the market. 

U.S. crude futures traded 1.2% higher at $54.20 a barrel, while the international benchmark Brent contract rose 1.1% to $56.98. 

Elsewhere, gold futures fell 0.7% to $1,851.80/oz, while silver futures were down 5.5% after their spike on Monday at $27.77/oz. EUR/USD traded 0.2% higher at 1.2077.

 

Latest comments

One Year Later: Stimulus Hopes...
vaccines hopes, stimulus hopes, covid advance concerns... it is really tiresome.
'moderate' republicans are living in a fantasy land in which they think their party actually matters.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.